
Alvotech Warrant
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- $1.66
- Today's High:
- $1.66
- Open Price:
- $1.66
- 52W Low:
- $0.3749
- 52W High:
- $3.11
- Prev. Close:
- $1.42
- Volume:
- 451
Company Statistics
- Market Cap.:
- $0
- Book Value:
- -10.059
- Revenue TTM:
- $39.68 million
- Operating Margin TTM:
- -577.99%
- Gross Profit TTM:
- $0
- Profit Margin:
- -255.78%
- Return on Assets TTM:
- -26.74%
- Return on Equity TTM:
- 0%
Company Profile
Alvotech Warrant had its IPO on 2022-06-16 under the ticker symbol ALVOW.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Alvotech Warrant has a staff strength of 784 employees.
Stock update
Shares of Alvotech Warrant opened at $1.66 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.66 - $1.66, and closed at $1.66.
This is a +16.9% increase from the previous day's closing price.
A total volume of 451 shares were traded at the close of the day’s session.
In the last one week, shares of Alvotech Warrant have slipped by -12.17%.
Alvotech Warrant's Key Ratios
Alvotech Warrant has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Alvotech Warrant’s revenue was $39.68 million with a gross profit of $0 and an EBITDA of $-220464992. The EBITDA ratio measures Alvotech Warrant's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Alvotech Warrant’s operating margin was -577.99% while its return on assets stood at -26.74% with a return of equity of 0%.
In Q4, Alvotech Warrant’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Alvotech Warrant’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Alvotech Warrant’s profitability.
Alvotech Warrant stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Alvotech Warrant stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $828.44 million
- Total Liabilities
- $167.29 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $10.47 million
- Dividend Payout Ratio
- 0%
Alvotech Warrant ended 2025 with $828.44 million in total assets and $0 in total liabilities. Its intangible assets were valued at $828.44 million while shareholder equity stood at $-564416000.00.
Alvotech Warrant ended 2025 with $0 in deferred long-term liabilities, $167.29 million in other current liabilities, in common stock, $-1654114000.00 in retained earnings and $11.64 million in goodwill. Its cash balance stood at $66.43 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $744.65 million.
Alvotech Warrant’s total current assets stands at $230.74 million while long-term investments were $48.57 million and short-term investments were $0. Its net receivables were $32.97 million compared to accounts payable of $49.19 million and inventory worth $71.47 million.
In 2025, Alvotech Warrant's operating cash flow was $0 while its capital expenditure stood at $10.47 million.
Comparatively, Alvotech Warrant paid $0 in dividends in 2025.
Other key metrics
- Current Trading Price
- $1.66
- 52-Week High
- $3.11
- 52-Week Low
- $0.3749
- Analyst Target Price
- $
Alvotech Warrant stock is currently trading at $1.66 per share. It touched a 52-week high of $3.11 and a 52-week low of $3.11. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $1.5 and 200-day moving average was $1.44 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Alvotech Warrant
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.